Evidera
Emmanuel A. Ojo is an experienced SAS Programmer and Data Analyst with a robust background in research and analytics, currently working at Thermo Fisher Scientific and Evidera since September 2022. Prior roles include SAS Programmer/Research Analyst at Harvard Pilgrim Health Care and Statistical Programmer at Boston University, among others. Ojo's expertise spans neurolinguistics and cognitive neuroscience, supported by educational credentials that include a Certificate in Computer Science from Boston University, a Master of Public Health in Research Epidemiology from Loma Linda University, and a Bachelor of Science in Biochemistry from Babcock University. Notable prior engagements include research as a Volunteer Clinical Research Assistant at Loma Linda University Medical Center and a Research Epidemiologist Intern at Loma Linda University School of Public Health.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.